LEADER 01525nam  2200397z- 450 
001 9910689438503321
005 20161209100811.0
035   $a(CKB)5600000000079878
035   $a(BIP)007465785
035   $a(EXLCZ)995600000000079878
100   $a20211123c2001uuuu  -u-         -
101 0 $aeng
200 14$aThe Anthrax Vaccine Immunization Program--what have we learned? $ehearings before the Committee on Government Reform, House of Representatives, One Hundred Sixth Congress, second session, October 3 and 11, 2000
215   $a1 online resource (iv, 1108 p.) $cill
311   $a0-16-066000-9 
517   $aAnthrax Vaccine Immunization Program--what have we learned? 
606   $aAnthrax$xVaccination$xComplications$zUnited States
606   $aVaccination$xComplications$zUnited States
606   $aBiological warfare$zUnited States$xSafety measures
607   $aUnited States$xArmed Forces$xMedical care
610   $aAnthrax
610   $aVaccination
610   $aBiological warfare
610   $aUnited nations
610   $aUnited States
610   $aMedical
610   $aHistory
610   $aPolitical science
615  0$aAnthrax$xVaccination$xComplications
615  0$aVaccination$xComplications
615  0$aBiological warfare$xSafety measures.
712 02$aU. S. Congress House Committee on Government Reform Staff,$4oth
906   $aBOOK
912   $a9910689438503321
996   $aThe Anthrax Vaccine Immunization Program--what have we learned$93168198
997   $aUNINA